The Science
Methylene Blue
vs Leuco Methylene Blue
A side-by-side examination of the oxidized and reduced forms of one of biochemistry's most versatile redox molecules — and why the interconversion between them matters.
Methylene Blue is the oxidized, cationic form of the compound. Its distinctive deep blue color arises from the delocalized π-electron system in the phenothiazinium ring. As a potent electron acceptor, MB⁺ readily accepts electrons from biological reducing agents such as NADH, NADPH, and ascorbate. It is the pharmacologically active form studied for neuroprotection, mitochondrial support, and antimicrobial applications.
Leuco Methylene Blue is the reduced, neutral form produced when MB⁺ gains two electrons and two protons. "Leuco" (from the Greek λευκός, white) signals the loss of the chromophore's conjugation — the compound becomes essentially colorless. LMB acts as an electron donor, returning electrons to the cycle. In living systems the MB⁺ ⇌ LMB cycle functions as a catalytic redox shuttle, continuously cycling between states.
- E°′ value: Cited as +0.011 V in the page banner (Wikipedia gives +0.01 V; the ScienceDirect review [3] lists it similarly). For precision, verify against Michaelis & Granick (1941), J. Gen. Physiol. 25:325–344 — the original primary source.
- Molecular weights: MB monohydrate (373.90 g/mol) and LMB (285.41 g/mol) — cross-check against PubChem CID 6099 (MB) and CID 135398513 (LMB).
- 65–85% reduction in erythrocytes: Sourced from DiSanto & Wagner (1972) as cited in [1]. The original pharmacokinetics paper is worth pulling for a therapeutic-context site.
- Cognitive / longevity claims: Labeled "investigational" throughout. Ensure any expanded content cites specific clinical trial data and includes appropriate disclaimers.
- Pro-oxidant at high dose: Well-established; referenced in [1] and [2]. Confirm dosage threshold figures if that content is expanded.
